Last week's SynBioBeta conference was indicative of the high degree of interest in the synthetic bio space from omics research tool vendors.
The San Francisco-based microbial genomics firm will sell off its product lines, testing labs, IP, and data within the next three months.
By analyzing metagenomic sequences found in thousands of human mouth and gut samples, researchers tracked down almost 45.7 million distinct microbial genes.
Researchers identified tumor microbe and immune differences in tumor samples from pancreatic ductal adenocarcinoma patients with exceptionally long survival.
In Nature this week: new CRISPR nuclease described, gut bacteria reference, and more.
Two research groups have cultured and sequenced microbes in fecal samples from healthy volunteers, producing new reference genomes for hundreds of species.
In PLOS this week: splice variant linked to lethal condition in bull terriers, sequencing to search for pathogens at hot springs, and more.
The researchers also found that niche-based processes underlie how the skin microbiomes of people living in megacities are assembled.
In PLOS this week: microRNA helps M. tuberculosis escape the immune system, application of genome-scale metabolic models to drug design, and more.
In PNAS this week: multi-omic analysis of Atlantic Ocean samples, miR-351 linked to hepatic fibrosis during Schistosoma infection, and more.
GenomeWeb reports that Veritas Genetics is suspending its US operations.
A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.
Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.
In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.